| 000 | 01489 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514032036.0 | ||
| 264 | 0 | _c20020910 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0028-3908 | ||
| 024 | 7 |
_a10.1016/s0028-3908(02)00009-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFaro, L R F | |
| 245 | 0 | 0 |
_aProtection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors. _h[electronic resource] |
| 260 |
_bNeuropharmacology _cApr 2002 |
||
| 300 |
_a612-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2-Amino-5-phosphonovalerate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDizocilpine Maleate _xpharmacology |
| 650 | 0 | 4 |
_aDopamine _xbiosynthesis |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aMethylmercury Compounds _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 700 | 1 | _ado Nascimento, J L M | |
| 700 | 1 | _aAlfonso, M | |
| 700 | 1 | _aDurán, R | |
| 773 | 0 |
_tNeuropharmacology _gvol. 42 _gno. 5 _gp. 612-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0028-3908(02)00009-6 _zAvailable from publisher's website |
| 999 |
_c11885789 _d11885789 |
||